Puma Biotechnology, Inc.PBYINASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank57
3Y CAGR-65.4%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-65.4%/yr
vs +4.5%/yr prior
Acceleration
-69.9pp
Decelerating
Percentile
P57
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.22-72.8%
20240.80-61.5%
20232.09-60.6%
20225.29+111.1%
2021-47.69-134.6%
2020-20.32-395.2%
20196.88+55.5%
20184.43+386.8%
20170.91-
20160.00-